{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:25:01Z","timestamp":1789071901083,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Argentine National Research Council","award":["PIP 0838"],"award-info":[{"award-number":["PIP 0838"]}]},{"name":"National Agency of Scientific and Technological Promotion (ANPCYT)","award":["PICT 0038"],"award-info":[{"award-number":["PICT 0038"]}]},{"name":"National Atomic Energy Commission (CNEA)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.mce.2018.08.007","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T23:21:06Z","timestamp":1534548066000},"page":"141-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Radiosensitivity enhancement of human thyroid carcinoma cells by the inhibitors of histone deacetylase sodium butyrate and valproic acid"],"prefix":"10.1016","volume":"478","author":[{"given":"Marina","family":"Perona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Thomasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Rossich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario A.","family":"Pisarev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinthia","family":"Rosemblit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela A.","family":"Cremaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Alejandra","family":"Dagrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7830-4539","authenticated-orcid":false,"given":"Guillermo J.","family":"Juvenal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2018.08.007_bib1","first-page":"1429","article-title":"Response to low-dose X-irradiation is p53-dependent in a papillary thyroid carcinoma model system","volume":"39","author":"Abou-El-Ardat","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.mce.2018.08.007_bib2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ijc.1002","article-title":"Loss of G2\/M arrest correlates with radiosensitization in two human sarcoma cell lines with mutant p53","volume":"96","author":"Bache","year":"2001","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.mce.2018.08.007_bib3","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1200\/JCO.2007.11.4991","article-title":"Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881\u201310882 trial","volume":"25","author":"Bartelink","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mce.2018.08.007_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijrobp.2010.03.010","article-title":"Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition","volume":"78","author":"Blattmann","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.mce.2018.08.007_bib5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.20774","article-title":"Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid","volume":"114","author":"Camphausen","year":"2005","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.mce.2018.08.007_bib6","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1158\/1078-0432.CCR-08-0643","article-title":"Postradiation sensitization of the histone deacetylase inhibitor VPA","volume":"14","author":"Chinnaiyan","year":"2008","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.mce.2018.08.007_bib7","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1677\/erc.1.01320","article-title":"Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition","volume":"13","author":"Chow","year":"2006","journal-title":"Endocr. Relat. Canc."},{"key":"10.1016\/j.mce.2018.08.007_bib8","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1158\/0008-5472.CAN-09-3028","article-title":"Inhibition of histone deacetylase in cancer cells slows down replication forks, activates dormant origins, and induces DNA damage","volume":"70","author":"Conti","year":"2010","journal-title":"Canc. Res."},{"key":"10.1016\/j.mce.2018.08.007_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s13277-010-0042-8","article-title":"Radiation-induced cell death mechanisms","volume":"31","author":"Eriksson","year":"2010","journal-title":"Tumor Biol."},{"key":"10.1016\/j.mce.2018.08.007_bib10","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/bjc.2013.21","article-title":"Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair","volume":"108","author":"Groselj","year":"2013","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.mce.2018.08.007_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ejso.2017.09.019","article-title":"Aggressive differentiated thyroid cancer","volume":"44","author":"Janjua","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.mce.2018.08.007_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrd772","article-title":"Histone-deacetylase inhibitors: novel drugs for the treatment of cancer","volume":"1","author":"Johnstone","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mce.2018.08.007_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4161\/epi.1.3.2896","article-title":"The epigenetic modifier, valproic acid, enhances radiation sensitivity","volume":"1","author":"Karagiannis","year":"2006","journal-title":"Epigenetics"},{"key":"10.1016\/j.mce.2018.08.007_bib14","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.dnarep.2011.07.003","article-title":"Histone deacetylase inhibitor sodium butyrate enhances cellular radiosensitivity by inhibiting both DNA nonhomologous end joining and homologous recombination","volume":"10","author":"Koprinarova","year":"2011","journal-title":"DNA Repair"},{"key":"10.1016\/j.mce.2018.08.007_bib15","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2015.04.038","article-title":"A phase 2 study of concurrent radiation therapy, temozolomide, and the histone deacetylase inhibitor valproic acid for patients with glioblastoma","volume":"92","author":"Krauze","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.mce.2018.08.007_bib16","first-page":"25","article-title":"Scriptaid, a novel histone deacetylase inhibitor, enhances the response of human tumor cells to radiation","volume":"25","author":"Kuribayashi","year":"2010","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.mce.2018.08.007_bib17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11596-011-0381-8","article-title":"Contribution of decreased expression of Ku70 to enhanced radiosensitivity by sodium butyrate in glioblastoma cell line (U251)","volume":"31","author":"Li","year":"2011","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.mce.2018.08.007_bib18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1039\/C5TX00476D","article-title":"Valproic acid causes radiosensitivity to breast cancer cells via disrupting DNA repair pathway","volume":"5","author":"Luo","year":"2016","journal-title":"Toxicol Res"},{"key":"10.1016\/j.mce.2018.08.007_bib19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.bbagrm.2010.05.008","article-title":"Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular function","volume":"1799","author":"Marks","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mce.2018.08.007_bib20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jcb.22185","article-title":"Histone deacetylase inhibitors: potential in cancer therapy","volume":"107","author":"Marks","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.mce.2018.08.007_bib21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1089\/thy.2007.0097","article-title":"Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines","volume":"17","author":"Meireles","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.mce.2018.08.007_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2307\/3577023","article-title":"Sensitivity to radiation of human normal, hyperthyroid, and neoplastic thyroid epithelial cells in primary culture","volume":"111","author":"Miller","year":"1987","journal-title":"Radiat. Res."},{"key":"10.1016\/j.mce.2018.08.007_bib23","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1158\/1078-0432.CCR-04-2088","article-title":"Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity","volume":"11","author":"Munshi","year":"2005","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.mce.2018.08.007_bib24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1134\/S0026893312010141","article-title":"Valproic acid decreases the reparation capacity of irradiated MOLT-4 Cells","volume":"46","author":"Muthna","year":"2012","journal-title":"Mol. Biol."},{"key":"10.1016\/j.mce.2018.08.007_bib25","first-page":"2075","article-title":"Radiation-induced G1 arrest is selectively mediated by the p53-WAF1\/Cip1 pathway in human thyroid cells","volume":"55","author":"Namba","year":"1995","journal-title":"Canc. Res."},{"key":"10.1016\/j.mce.2018.08.007_bib26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijrobp.2003.09.028","article-title":"Phosphorylation of histone H2AX as a measure of radiosensitivity","volume":"58","author":"Olive","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.mce.2018.08.007_bib27","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1667\/RR2658.1","article-title":"Protection against radiation-induced damage of 6-propyl-2-thiouracil (PTU) in thyroid cells","volume":"179","author":"Perona","year":"2013","journal-title":"Radiat. Res."},{"key":"10.1016\/j.mce.2018.08.007_bib28","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1158\/1078-0432.CCR-10-0523","article-title":"Histone gammaH2AX and poly(ADP-ribose) as clinical pharmacodynamic biomarkers","volume":"16","author":"Redon","year":"2010","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.mce.2018.08.007_bib29","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1073\/pnas.0830918100","article-title":"Evidence for a lack of DNA double-strand break repair in human cells exposed to very low X-ray doses","volume":"100","author":"Rothkamm","year":"2003","journal-title":"ProcN atl Acad Sci US A"},{"key":"10.1016\/j.mce.2018.08.007_bib30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12944-017-0593-4","article-title":"Sodium butyrate promotes apoptosis in breast cancer cells through reactive oxygen species (ROS) formation and mitochondrial impairment","volume":"16","author":"Salimi","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.mce.2018.08.007_bib31","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1111\/j.1582-4934.2011.01296.x","article-title":"Grand rounds at the National Institutes of Health: HDAC inhibitors as radiation modifiers, from bench to clinic","volume":"15","author":"Shabason","year":"2011","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.mce.2018.08.007_bib32","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ijrobp.2008.05.012","article-title":"Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: memorial Sloan-Kettering Cancer Center experience","volume":"73","author":"Terezakis","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.mce.2018.08.007_bib33","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00415-009-5156-9","article-title":"Efficacy of anti-epileptic drugs in patients with gliomas and seizures","volume":"256","author":"van Breemen","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.mce.2018.08.007_bib34","first-page":"397","article-title":"Enhancement of sodium butyrate-induced cell death and apoptosis by X-irradiation in the human colorectal cancer cell line HCT 116","volume":"20","author":"Wei","year":"2008","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.mce.2018.08.007_bib35","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2008.10.047","article-title":"HDAC expression and clinical prognosis in human malignancies","volume":"280","author":"Weichert","year":"2009","journal-title":"Canc. Lett."},{"key":"10.1016\/j.mce.2018.08.007_bib36","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1007\/s00018-014-1656-6","article-title":"Histone deacetylase inhibitors and cell death","volume":"71","author":"Zhang","year":"2014","journal-title":"Cell. Mol. Life Sci."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720718302508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720718302508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T11:35:38Z","timestamp":1539430538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720718302508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":36,"alternative-id":["S0303720718302508"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2018.08.007","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiosensitivity enhancement of human thyroid carcinoma cells by the inhibitors of histone deacetylase sodium butyrate and valproic acid","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2018.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}